Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01805661 · ClinicalTrials.gov registry record · NA

Adductor Canal Block With Posterior Capsular Injection for Total Knee Replacement

A NA study of Pain and Osteoarthritis, sponsored by Trinity Health Of New England.

Completed
Registry status
NA
Development phase
56
Enrollment target
1
Study location

NCT01805661: Completed NA study of Pain and Osteoarthritis, sponsored by Trinity Health Of New England.

NCT01805661 is a NA study of Pain and Osteoarthritis that has completed, run by Trinity Health Of New England. The registered enrollment target is 56 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01805661, a NA study of Pain and Osteoarthritis, has completed, sponsored by Trinity Health Of New England.

COMPLETED
Registry status
NA
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

To compare early ambulation and ability to participate in rehabilitation in patients undergoing total knee replacement using two different nerve block techniques for pain control. The 2 methods are 1) Adductor canal block with posterior capsular injection 2) femoral nerve block with tibial nerve block

Primary Outcome

Ability to ambulate and perform tasks of the rehabilitation program and reach rehabilitation milestones after total knee arthroplasty.

Conditions Studied

Interventions

  • PROCEDURE Canal Block and Capsular Injection
  • PROCEDURE Femoral with Tibial Nerve Block

Study Locations (1)

Connecticut

  • Saint Francis Hospital and Medical Center - Hartford

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2013-03
Est. Completion 2013-12
Phase NA
Trinity Health Of New England

20 total trials

What the finished NCT01805661 record still lists

NCT01805661 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (82% lower).

The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Canal Block and Capsular Injection is the first listed.

NCT01805661 reports a single indexed study location in Connecticut.

Frequently Asked Questions

What is clinical trial NCT01805661 about?

NCT01805661 is a clinical study titled "Adductor Canal Block With Posterior Capsular Injection for Total Knee Replacement". To compare early ambulation and ability to participate in rehabilitation in patients undergoing total knee replacement using two different nerve block techniques for pain control. The 2 methods are 1) Adductor canal block with posterior capsular injection 2) femoral nerve block with tibial nerve blo...

What is the current status of trial NCT01805661?

This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2013-03. Estimated completion is 2013-12.

What conditions does trial NCT01805661 study?

This clinical trial studies the following conditions: Pain, Osteoarthritis.

What interventions are being tested in trial NCT01805661?

The interventions under investigation include: Canal Block and Capsular Injection (PROCEDURE), Femoral with Tibial Nerve Block (PROCEDURE).

Who is sponsoring clinical trial NCT01805661?

This trial is sponsored by Trinity Health Of New England, which has 20 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01805661 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01805661's enrollment target sits among peer trials

56 245th of 374 higher than 127 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02287428 · 56 participants · Phase 1

    Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

  • NCT02923011 · 56 participants · Phase 3

    Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas

  • NCT02935283 · 56 participants

    Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders

  • NCT03375866 · 56 participants · NA

    Effects of Mixed Nut Consumption on Satiety and Weight Management

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01805661, the US trial registry maintained by the National Library of Medicine. NCT01805661 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.